title: LDL-apheresis with dextran sulphate and anaphylactoid reactions to ACE inhibitors.
authors.forename: C
authors.initials: C
authors.lastname: Keller
authors.forename: P
authors.initials: P
authors.lastname: Grützmacher
authors.forename: F
authors.initials: F
authors.lastname: Bahr
authors.forename: A
authors.initials: A
authors.lastname: Schwarzbeck
authors.forename: A A
authors.initials: AA
authors.lastname: Kroon
authors.forename: A
authors.initials: A
authors.lastname: Kiral
mesh_terms: D000707:Anaphylaxis / Q000209:etiology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D001781:Blood Component Removal / Q000009:adverse effects*; D016264:Dextran Sulfate / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000209:etiology*; D006801:Humans; D008077:Lipoproteins, LDL
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D008077:Lipoproteins, LDL; D016264:Dextran Sulfate